A patient taking ethambutol develops a sore throat and fever. What is the appropriate nursing action?

Choice A rationale Ethambutol is an antituberculosis medication. The combination of a sore throat and fever can be indicative of a serious and potentially life-threatening adverse effect of the medication, such as hepatotoxicity or bone marrow suppression, which could manifest as agranulocytosis. Continuing the medication would be highly dangerous and could worsen the patient's condition. Choice B rationale Sore throat and fever can signal a severe systemic reaction to ethambutol, potentially indicating drug-induced agranulocytosis or hepatotoxicity. Agranulocytosis, characterized by a critically low white blood cell count (normal range for WBC is 4,500 to 11,000 cells/mm), leaves the body vulnerable to overwhelming infection. Immediate discontinuation of the drug and notifying the healthcare provider is the essential nursing action. Choice C rationale Increasing the dose of a medication when a patient is exhibiting signs of a potential adverse drug reaction is contraindicated. The symptoms of sore throat and fever suggest a systemic inflammatory or immune response to the drug. Increasing the dose would likely exacerbate the toxicity and further harm the patient, potentially leading to a more severe outcome. Choice D rationale A sore throat and fever in a patient on ethambutol could be a sign of a severe adverse drug reaction, not just a simple bacterial infection. While an infection may be present, the primary concern is the potential for bone marrow suppression. Prescribing an antibiotic without a proper diagnosis would be an inappropriate nursing action, as it is outside the scope of practice and would fail to address the underlying issue.